| EDITORIALS |
| 357 | Rehabilitation following hospitalization in patients with COPD: Can it reduce readmissions?
Lissa M Spencer
See article, page 395 |
| 359 | Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: Does it take these two to tango?
Maria I Velez & Anoop M Nambiar
See article, page 445 |
| INVITED REVIEW SERIES |
| Challenges in Drug Development for Chronic Lung Diseases |
| 361 | Delayed access to treatments for rare diseases: Who's to blame?
Karen Feltmate, Peter M Janiszewski, Sheena Gingerich & Michael Cloutier |
| Lung Cancer Practice, Implementing Evidence From Around the World |
| 370 | Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
Nesaretnam Barr Kumarakulasinghe, Nico van Zanwijk & Ross A Soo |
| Respiratory Disease: Using Lung Function Measurements To Greater Advantage |
| 379 | Respiratory disease and respiratory physiology: Putting lung function into perspective: Paediatric asthma
Lara S van den Wijngaart, Jolt Roukema & Peter J F M Merkus
See case report in Respirology Case Reports http://dx.doi.org/10.1002/rcr2.92
Watch the Video introducing the Review Series on lung function testing |
| INVITED REVIEW |
| 389 | Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective
Yuben Moodley, Tamera Corte, Luca Richeldi & Talmadge E King Jr |
| REVIEWS |
| 395 | Rehabilitation following hospitalization in patients with COPD: Can it reduce readmissions?
Matthew Maddocks, Samantha S C Kon, Sally J Singh & William D-C Man
See Editorial, page 357 |
| 405 | Incidence of viral infection detected by PCR and real-time PCR in childhood community-acquired pneumonia: A meta-analysis
Min Wang, Feng Cai, Xiaodong Wu, Ting Wu, Xin Su & Yi Shi |
| ORIGINAL ARTICLES |
| COPD |
| 413 |
Impact of comorbidities on physical activity in COPD
Noriane A Sievi, Oliver Senn, Thomas Brack, Martin H Brutsche, Martin Frey, Sarosh Irani, Jörg D Leuppi, Robert Thurnheer, Daniel Franzen, Malcolm Kohler & Christian F Clarenbach
See Editor's Choice, page 519 |
| 419 | Oxygen desaturation and adverse events during 6-min walk testing in patients with COPD
Mary M Roberts, Jin-Gun Cho, Jacqueline S Sandoz & John R Wheatley |
| 426 | Tc17 cells are associated with cigarette smoke-induced lung inflammation and emphysema
Hongbin Zhou, Wen Hua, Yan Jin, Chao Zhang, Luanqing Che, Lixia Xia, Jiesen Zhou, Zhihua Chen, Wen Li & Huahao Shen |
| Interstitial Lung Disease |
| 434 | Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation?
Vicki Johnson-Warrington, Louise Sewell, Mike Morgan & Sally Singh |
| 439 | MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis
Yasushi Horimasu, Shinichiro Ohshimo, Francesco Bonella, Sonosuke Tanaka, Nobuhisa Ishikawa, Noboru Hattori, Nobuoki Kohno, Josune Guzman & Ulrich Costabel |
| 445 |
Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
Susumu Sakamoto, Yoko Muramatsu, Keita Satoh, Fumiaki Ishida, Naoshi Kikuchi, Go Sano, Keishi Sugino, Kazutoshi Isobe, Yujiro Takai & Sakae Homma
See Editorial, page 359
See Editor's Choice, page 519 |
| Interventional Pulmonology |
| 453 | Differentiating benign from malignant mediastinal lymph nodes visible at EBUS using grey-scale textural analysis
Anthony J Edey, Adrian Pollentine, Claire Doody & Andrew R L Medford |
| Lung Function |
| 459 | Effect of equipment dead space on multiple breath washout measures
Anouk Benseler, Sanja Stanojevic, Renee Jensen, Per Gustafsson & Felix Ratjen |
| Paediatric lung disease |
| 467 | Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking
Diane Gray, Dorottya Czövek, Emilee Smith, Lauren Willemse, Ane Alberts, Zoltán Gingl, Graham L Hall, Heather J Zar, Peter D Sly & Zoltán Hantos |
| Pleural Disease |
| 474 | Pulmonary manifestations in systemic lupus erythematosus: Association with disease activity
Omer S B Alamoudi & Suzan M Attar |
| Pulmonary Vascular Disease |
| 481 | Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension
Saghar Sadeghi, John T Granton, Pooneh Akhavan, Christopher R Pasarikovski, Adrienne M Roos, John Thenganatt, Jakov Moric & Sindhu R Johnson |
| Tuberculosis |
| 488 | Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis
Sung-Soo Jung, Hee-Sun Park, Ju-Ock Kim & Sun-Young Kim |
| 496 | T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts
Chi Chiu Leung, Wing Cheong Yam, Pak Leung Ho, Wing Wai Yew, Chi Kuen Chan, Wing Sze Law, Shuk Nor Lee, Kwok Chiu Chang, Lai Bun Tai & Cheuk Ming Tam |
| SCIENTIFIC LETTERS |
| 504 | Cohort study of a simple 'Step-Up' regimen with the Asthma Control Test
Shaun Holt, Mitesh Patel, Barney Montgomery, Mark Weatherall & Richard Beasley |
| 507 | Pleural empyema caused by Klebsiella oxytoca: A case series
Elizabeth Suthers, Andrew Rosenstengel, Julie Hart, Joshua R Lewis, Ian Kay, Grant Waterer, Y C Gary Lee & Fraser Brims |
| YEAR IN REVIEW |
| 510 | Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology
Tow Keang Lim, Fanny W S Ko, Paul S Thomas, Chris Grainge & Ian A Yang |
| EDITOR'S CHOICE |
| 519 | The Editor recommends this issue's articles
Impact of comorbidities on physical activity in COPD
N A Sievi, O Senn, T Brack, MH Brutsche, M Frey, S Irani, JD Leuppi, R Thurnheer, D Franzen, M Kohler & CF Clarenbach
See page 413
Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
S Sakamoto, Y Muramatsu, K Satoh, F Ishida, N Kikuchi, G Sano, K Sugino, K Isobe, Y Takai & S Homma
See page 445 |
